http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI#Head http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI#assertion http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI#provenance http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI#pubinfo http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI#assertion http://purl.obolibrary.org/obo/DOID_8534 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_8534 http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00585 http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI#association http://www.w3.org/2000/01/rdf-schema#label nizatidineoral solution is indicated for up to 8 weeks for the treatment of active duodenal ulcer in most patients the ulcer will heal within 4 weeks nizatidineoral solution is indicated for maintenance therapy for duodenal ulcer patients at a reduced dosage of 15 mg h s after healing of an active duodenal ulcer the consequences of continuous therapy with nizatidine for longer than 1 year are not known nizatidine oral solution is indicated for up to 12 weeks for the treatment of endoscopically diagnosed esophagitis including erosive and ulcerative esophagitis and associated heartburn due to gerd nizatidine oral solution is indicated for up to 8 weeks for the treatment of active benign gastric ulcer before initiating therapy care should be taken to exclude the possibility of malignant gastric ulceration in pediatric patients nizatidine oral solution is indicated for ages 12 years and older nizatidine oral solution is indicated for up to 8 weeks for the treatment of endoscopically diagnosed esophagitis including erosive and ulcerative esophagitis and associated heartburn due to gerd http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00585 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI#provenance http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI#pubinfo http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI#sig http://purl.org/nanopub/x/hasSignature g3LBJZrh126k5BIiQu4qjGWSQh5XufqmwF9sWiEyxzlQSwF0+T+xaiSiQDW0EN8IJOPzVZyc32+yIwweM38qUO+kUkUfAuU2xBCFtre3fa8c/9V1s+WtPu3Gy5TuhezWl6SRIUzuj7Ow2eAKCsPk99FVjH9V6af/zcuV908XX8Y= http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI http://purl.org/dc/terms/created 2021-06-29T08:20:07.308+02:00 http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RA7VYMljtqqpjolFFdKWrP5I-6ydYlXahxQYHmRYAPmAI https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs